Abstract
Background
The aim of the present study was to evaluate the efficacy of pentoxifylline and tocopherol for the management of osteoradionecrosis of the jaws.
Methods
Twenty-five patients diagnosed with osteoradionecrosis of the jaws treated with pentoxifylline 400 mg + tocopherol 400 mg three times daily (tid) were evaluated. Clinical records and image tests were reviewed. All patients were previously submitted to head and neck radiation therapy and presented with a clinical and radiographic diagnosis of osteoradionecrosis of the jaws.
Results
Following therapy with pentoxifylline and tocopherol, 76% (19/25) of the patients showed complete mucosal healing, in which 47.3% (9/19) did not undergo sequestrectomy. From this particular group, 77.7% (7/9) were in stage I and 33.3% (3/9) used the protocol for up to 3 months. Among those who underwent to sequestrectomy, complete mucosal healing was observed in 52.7% (10/19). Among these, 60% (6/10) were in stage I and 100% of the patients were using the protocol for more than 3 months. In all other patients, partial healing of the mucosa was observed since they presented advanced disease. These represented 24% of the sample (6/25), 66.6% (4/6) were in stage III, and 60% (4/6) used the protocol for over 6 months.
Conclusion
Pentoxifylline and tocopherol may provide effective management of osteoradionecrosis of the jaws, and the association with sequestrectomy may avoid major surgical procedures.
Similar content being viewed by others
References
Ribeiro ILA, Medeiros JJ, Rodrigues LV, Valença AMG, Neto EAL (2015) Fatores associados ao câncer de lábio e cavidade oral. Rev Bras Epidemiol 18(3):618–629
Instituto Nacional De Câncer José Alencar Gomes Da Silva (INCA) - Coordenação de Prevenção e Vigilância (2018) Estimativa 2018: incidência de câncer no Brasil. https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-incidencia-de-cancer-no-brasil-2018.pdf Access on September 25, 2019
Patel V, McGurk M (2017) Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy. Br J Oral Maxillofac Surg 55(3):235–241
Santos RCS, Dias RS, Giardani AJ, Segreto RA, Segreto HRC (2011) Mucosite em pacientes portadores de câncer de cabeça e pescoço submetidos à radioterapia e quimioterapia. Rev Esc Enferm USP 45(6):1338–1344
Shin DM, Khuri FR (2011) Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck 35(3):443–453
Koyfman SA, Brizel DM, Posner MR (2019) General principles of radiation therapy for head and neck cancer. UpToDate
Nabil S, Samman N (2011) Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg 40(3):229–243
Moura JFB, Lima RP (2015) Tumores de cabeça e pescoço - Radioterapia em oncologia. Atheneu, São Paulo, pp 505–515
Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H (2017) The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and Women’s Cancer Center Multidisciplinary Guideline. Oncologist 22(3):343–350
Ramli R, Ngeow WC, Rahman RA, Chai WL (2006) Managing complications of radiation therapy in head and neck cancer patients: part IV. Management of osteoradionecrosis. Singap Dent J 28(1):11–15
Lyons A, Ghazali N (2008) Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 46(8):653–660
Pitak-Arnnop P, Sader R, Dhanuthai K, Masaratana P, Bertolus C, Chaine A, Bertrand JC, Hemprich A (2008) Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol 34(10):1123–1134
Lyons A, Brennan P (2017) Pentoxifylline – a review of its use in osteoradionecrosis. Br J Oral Maxillofac Surg 55(3):230–234
Delanian S, Lefaix JL (2000) Refractory osteoradionecrosis: striking healing with a combination of pentoxifylline-tocopherol. Abstract presented at 19th annual ESTRO Meeting, Istanbul. Radiother Oncol 56:129
Delanian S, Depondt J, Lefaix JL (2005) Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 27(2):114–123
Patel V, Gadiwalla Y, Sassoon I, Sproat C, Kwok J, McGurk M (2016) Use of pentoxifylline and tocopherol in the management of osteoradionecrosis. Br J Oral Maxillofac Surg 54(3):342–345
Kolokythas A, Rasmussen JT, Reardon J, Feng C (2019) Management of osteoradionecrosis of the jaws with pentoxifylline-tocopherol: a systematic review of the literature and meta-analysis. Int Oral Maxillofac Surg 48(2):173–180
Hamama S, Delanian S, Monceau V, Vozenib MC (2012) Therapeutic management of intestinal fibrosis induced by radiation therapy: from molecular profiling to new intervention strategies et vice et versa. Fibrogenesis Tissue Repair 5(1):13
Raoul G, Maes JM, Pasquier D, Nicola J, Ferri J (2005) Ostéoradionécrose des maxillaires (maxillaire et mandibulaire). EMC-Stomatologie 1(4):255–276
Instituto Nacional De Câncer José Alencar Gomes Da Silva (INCA) - Coordenação de Prevenção e Vigilância. Estimativa 2016: incidência de câncer no Brasil. http://santacasadermatoazulay.com.br/wp-content/uploads/2017/06/estimativa-2016-v11.pdf Access on September 25, 2019
Teng MS, Futran ND (2005) Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg 13(4):217–221
Chronopoulos A, Zarra T, Ehrenfeld M, Otto S (2017) Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J 68(1):22–30
Rice N, Polyzois I, Ekanayake K, Omer O, Leo FA, Stassen A (2015) The management of osteoradionecrosis of the jaws—a review. Surgeon 13(2):101–109
Marx RE, Johnson RP (1987) Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64(4):379–390
Aldunate B, Coltro OS, Busnardo FF, Ferreira MC (2010) Osteorradionecrose em face: fisiopatologia, diagnóstico e tratamento. Rev Bras Cir Plást 25(2):381–387
Notani K, Yamazaki Y, Kitada H, Sakakibara N, Fukuda H, Omori K, Nakamura M (2003) Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 25(3):181–186
Chronopoulos A (2015) Clinical presentation and risk factors of osteoradionecrosis. Doctoral dissertation, LMU München: Faculty of Medicine
Li YX, Weber-Johnson K, Sun LQ, Paschoud N, Mirimanoff RO, Coucke PA (1998) Effect of pentoxifylline on radiation induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiat Res 149(4):338–342
Gude RP, Binda MM, Boquete AL, Bonfil RD (2001) Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. J Cancer Res Clin Oncol 127(10):625–630
Lang T, Johanning K, Metzler H, Piepenbock S, Solomon C, Rahe-Meyer N, Tanaka KA (2009) The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analog 108(3):751–758
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There was no funding for this research. The costs were covered by the main researcher. There is full control of all primary data and we allow the journal to review the data if requested.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
dos Anjos, R.S., de Pádua Walfrido, G.N., de Hollanda Valente, R.O. et al. Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws—a case series. Support Care Cancer 29, 3311–3317 (2021). https://doi.org/10.1007/s00520-020-05847-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05847-6